Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Duta Pertiwi Tbk (DUTI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Duta Pertiwi TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Duta Pertiwi Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Duta Pertiwi Tbk trades at Rp4,090 (market cap 7.57T, 3.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Duta Pertiwi Tbk is far larger — about 13.1× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 3.2K). Which is the better fit depends on your goals.

DUTILABS
Market Cap
7.57T576.7B
Volume
3.2K3.48M
Lot
3234.82K
Turnover
13.09M522.79M
Average Price
4,090150.13
Value
13.09M522.79M
Indicative Equilibrium Price
4,090148
Indicative Equilibrium Volume
1350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DUTI
View details
LABS
View details

About Duta Pertiwi Tbk

PT. Duta Pertiwi Tbk (the Company) was established based on Notarial Deed No. 237 dated December 29, 1972 of Mohamad Said Tadjoedin, S.H., a public notary in Jakarta. The Company operates and engaged in commercial mixed use development (i.e. shophouse, kiosk/small retail space, strata office space) as well as housing, shopping center, apartment, and hotel developments.

Read more on DUTI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS